How architectural claims are evaluated under oncogenic load through adversarial testing.
Architectural Oncology advances claims about malignant persistence and collapse that are only meaningful if persistence can be broken under therapeutic perturbation and collapse can be induced by crossing a feasibility boundary. Accordingly, architectural hypotheses are evaluated through adversarial testing under sustained oncogenic load, using regimes that push malignant architectures toward their feasibility limits.
Evidence is considered admissible only when claims are tested in regimes where malignant systems remain maximally executable under local perturbation, yet operate near a feasibility boundary. Collapse is specifically inducible by perturbing the putative architectural dependency under load.
